BIOASTER is a Technological Research Institute created in April 2012 by Institut Pasteur and Lyonbiopole at the initiative of the French government and private life science companies. BIOASTER is a not-for-profit scientific cooperation foundation dedicated to microbiology and infectious diseases, tackling diseases linked to or caused by bacteria, viruses, parasites, and fungi. We offer a new approach to R&D, by integrating scientific and technological innovations through collaborations in applied translational science.  By fostering multidisciplinary collaborations turned towards open innovation, BIOASTER accelerates the development of health products focused on patient needs. With an industry expertise in the fields of diagnostics, vaccines, antimicrobials, and microbiome development, technologies developed at BIOASTER encompass ad hoc complex pre/clinical studies, multi-omics analyses, microsystems, organ on a chip, cellular/molecular optical engineering, high content data integration and machine learning/artificial Intelligence.

Located in Lyon and Paris, BIOASTER has more than 100 employees including 80 world-class scientists and engineers originating from 16 different countries.